Trial
NCT02206776
Randomized Controlled Trial of Intranasal Ketamine vs. Intranasal Midazolam in Individuals With OCD
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
New York State Psychiatric Institute
Collaborators
—
Condition
Obsessive-Compulsive Disorder
Intervention
Intranasal Ketamine
Why stopped
poor tolerability and low enrollment rate
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-05-03